LEO 90105 Ointment in Japanese Subjects With Psoriasis

Phase 3 Completed 676 enrolled LEO Pharma Quintiles, Inc. · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to compare the efficacy of LEO 90105 ointment applied once daily with Dovonex® ointment applied twice daily and with Rinderon®-DP ointment applied once daily in Japanese subjects with psoriasis vulgaris.

Timeline

Start: 2011-07
Primary completion: 2012-04
Completion: 2012-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Calcipotriol	Small molecule	—	Topical
Comparator	betamethasone dipropionate	Small molecule	—	Topical

LEO 90105 Ointment in Japanese Subjects With Psoriasis

Summary

Timeline

Drugs

Indications